Results 31 to 40 of about 52,894 (243)

Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies

open access: yesMolecules, 2023
This study investigates the development of topically applied non-invasive amino-functionalized silica nanoparticles (AMSN) and O-Carboxymethyl chitosan-coated AMSN (AMSN-CMC) for ocular delivery of 5-Fluorouracil (5-FU).
Adel Ali Alhowyan   +7 more
doaj   +1 more source

Uio-68-5-FU as a drug delivery platform for 5-FU

open access: yes, 2022
The drug delivery application of Porous metal–organic frameworks (MOFs) have been investigated due to their unique structures which are built of inorganic nodes and organic ligands. In present study, Uio-68-5-FU was successfully prepared by applied for delivery of 5-fluorouracil (5-FU).
openaire   +2 more sources

Locally-applied 5-fluorouracil-loaded slow-release patch prevents pancreatic cancer growth in an orthotopic mouse model [PDF]

open access: yes, 2019
To obtain improved efficacy against pancreatic cancer, we investigated the efficacy and safety of a locally-applied 5-fluorouracil (5-FU)-loaded polymeric patch on pancreatic tumors in an orthotopic nude-mouse model.
CHO, DONG WOO   +10 more
core   +1 more source

Uio-66-5-FU as a drug delivery platform for 5-FU

open access: yes, 2022
The drug delivery application of Porous metal–organic frameworks (MOFs) have been investigated due to their unique structures which are built of inorganic nodes and organic ligands. In present study, Uio-66-5-FU was successfully prepared by applied for delivery of 5-fluorouracil (5-FU).
openaire   +1 more source

Quercetin synergistically induces sensitivity to 5-fluorouracil through p53 modulation in colorectal cancer cells [PDF]

open access: yes, 2011
Colorectal tumors (CRC) with microsatellite instability (MSI) show resistance to chemotherapy with 5-fluorouracil (5-FU), the most widely used pharmacological drug for CRC treatment.
Lima, Cristóvão F.   +2 more
core   +1 more source

Diet and the risk of inflammatory bowel disease: A retrospective cohort study in Taiwan

open access: yesJournal of the Formosan Medical Association
Background/purpose: The incidence of inflammatory bowel disease (IBD) rapidly increases in Asia, and western dietary pattern is suspected to be the major risk factor.
Ming Jung Meng   +6 more
doaj   +1 more source

Selective Chemical Labeling of Natural T Modifications in DNA. [PDF]

open access: yes, 2015
We present a chemical method to selectively tag and enrich thymine modifications, 5-formyluracil (5-fU) and 5-hydroxymethyluracil (5-hmU), found naturally in DNA.
Balasubramanian, Shankar   +3 more
core   +2 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

An RNA damage response network mediates the lethality of 5-FU in colorectal cancer

open access: yesCell Reports Medicine
Summary: 5-fluorouracil (5-FU), a major anti-cancer therapeutic, is believed to function primarily by inhibiting thymidylate synthase, depleting deoxythymidine triphosphate (dTTP), and causing DNA damage.
Jung-Kuei Chen   +19 more
doaj   +1 more source

Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation [PDF]

open access: yes, 2003
Objectives: To evaluate the clinical and costeffectiveness of capecitabine and tegafur with uracil (UFT/LV) as first-line treatments for patients with metastatic colorectal cancer, as compared with 5- fluorouracil/folinic acid (5-FU/FA) regimens.
Brewer, N.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy